Recent Finacing
Recent Raise
Mucosis is a clinical-stage biotech developing needle-free mucosal vaccines using a proprietary Mimopath platform for intranasal or oral delivery, advancing SynGEM (RSV), FluGEM (influenza), and PneuGEM (pneumococcal).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors